Capital Change Notice - Issue of Employee Share Rights

13 September 2023
Issue of ordinary shares
This notice is given under NZX Listing Rule 3.13.1 and relates to unlisted Employee Share Rights to acquire ordinary shares in the Company (‘ESRs’) issued under the Fisher & Paykel Healthcare Employee Share Rights Plan (the ‘Employee Share Rights Plan’).

Section 1: Issuer information
Name of issuer Fisher & Paykel Healthcare Corporation Limited
NZX ticker code FPH
Class of financial product Unlisted ESRs to acquire ordinary shares in the Company issued under the Employee Share Rights Plan
ISIN (If unknown, check on NZX website) NZFAPE0001S2
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed 173,829
Nominal value (if any) Not applicable
Issue/acquisition/redemption price per security No amount is payable for the grant of ESRs. One ESR will convert into one ordinary share at no cost after three years, provided the recipient remains an employee of the Company.
Nature of the payment (for example, cash or other consideration) Not applicable
Amount paid up (if not in full) Not applicable
Percentage of total class of Financial Products issued/acquired/redeemed/ (calculated on the number of Financial Products of the Class, excluding any Treasury Stock, in existence) 173,829 ESRs to acquire ordinary shares representing approximately 0.02988% of the ordinary shares on issue.
For an issue of Convertible Financial Products or Options, the principal terms of Conversion (for example the Conversion price and Conversion date and the ranking of the Financial Product in relation to other Classes of Financial Product) or the Option (for example, the exercise price and exercise date) Not Applicable
Reason for issue/acquisition/redemption and specific authority for issue/acquisition/redemption/ (the reason for change must be identified here) Issue of ESRs under the Employee Share Rights Plan to incentivise selected employees to grow the Company and to attract, motivate and retain key employees.
Total number of Financial Products of the Class after the issue/acquisition/redemption/Conversion (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue/acquisition/redemption. 406,230 ESRs
In the case of an acquisition of shares, whether those shares are to be held as treasury stock Not applicable
Specific authority for the issue, acquisition, or redemption, including a reference to the rule pursuant to which the issue, acquisition, or redemption is made Directors’ resolution dated 29 August 2023.
Terms or details of the issue, acquisition, or redemption (for example: restrictions, escrow arrangements) The ESRs will be issued on the terms of the Employee Share Rights Plan approved by the Board.
Date of issue/acquisition/redemption 12 September 2023
Section 3: Authority for this announcement and contact person
Name of person authorised to make this announcement Raelene Leonard
Contact person for this announcement Raelene Leonard
Contact phone number +64 9 574 0147
Contact email address [email protected]
Date of release through MAP 13 September 2023

---

Announcement PDF